Table I.
Characteristics | Category | Number |
---|---|---|
Sex | M | 50 |
F | 7 | |
Age at diagnosis, mean years ± SD | 52.1±10.6 | |
BMI index | <18.5 | 2 |
18.5–23.9 | 24 | |
>23.9 | 31 | |
Smoking | Yes | 21 |
Occasionally | 3 | |
No | 31 | |
N/A | 2 | |
Alcohol | Yes | 15 |
Occasionally | 5 | |
No | 35 | |
N/A | 2 | |
HBV | Yes | 42 |
No | 15 | |
Alcoholic hepatitis | Yes | 5 |
No | 52 | |
Fatty liver | Yes | 3 |
No | 53 | |
N/A | 1 | |
Cirrhosis and liver fibrosis | Yes | 41 |
No | 15 | |
N/A | 1 | |
Family cancer history | Yes | 27 |
No | 30 | |
Hepatectomy surgery | Yes | 51 |
No | 3 | |
N/A | 3 | |
ECOG score | 0 | 52 |
1 | 4 | |
N/A | 1 | |
Metastases | Yes | 6 |
No | 50 | |
N/A | 1 | |
Degree of differentiation | Undifferentiated | 0 |
Low | 5 | |
Middle | 49 | |
High | 0 | |
N/A | 3 | |
Largest diameter of the | <2 | 4 |
tumor, cm | 2–5 | 22 |
5–10 | 18 | |
≥10 | 9 | |
NA | 4 | |
Albumin, g/l | <35 | 6 |
35–50 | 49 | |
>50 | 1 | |
N/A | 1 | |
Bilirubin, mg/l | 1–10 | 20 |
>10 | 36 | |
N/A | 1 | |
Platelet | <100 | 9 |
100–300 | 43 | |
>300 | 4 | |
N/A | 1 | |
AFP (ng/ml) | <25 | 34 |
25–500 | 11 | |
>500 | 11 | |
N/A | 1 | |
ALT | 0–40 | 36 |
>40 | 19 | |
N/A | 2 | |
Child-Pugh classification | 0/A | 52 |
B/C/D | 1 | |
N/A | 4 | |
BCLC | 0/A | 12 |
B | 23 | |
C | 16 | |
N/A | 6 | |
Stage | I | 2 |
II | 28 | |
III | 17 | |
IV | 7 | |
N/A | 3 | |
Lesion | Primary | 52 |
Secondary | 2 | |
N/A | 3 | |
Nodules | Single | 42 |
Multiple | 14 | |
N/A | 1 | |
Number of tumors | 1 | 42 |
>1 | 7 | |
N/A | 8 | |
Microvascular invasion (tumor thrombus) | Yes | 44 |
No | 9 | |
N/A | 4 | |
Large vascular invasion (tumor thrombus) | Yes | 4 |
No | 49 | |
N/A | 4 | |
Portal vein invasion (tumor thrombus) | Yes | 9 |
No | 44 | |
N/A | 4 | |
Peripheral nerve invasion | Yes | 4 |
No | 49 | |
N/A | 4 |
SD, standard deviation; BMI, body mass index; HBV, hepatitis B virus; AFP, α-fetoprotein; ALT, alanine aminotransferase; BCLC, Barcelona Clinic Liver Cancer; NA, not available.